https://orcid.org/0000-0002-7636-8368
References
- Verma L, Venkatesh P, Chawla R, Tewari HK, Chawla R and Tewari H. Choroidal detachment following retinal detachment surgery: an analysis and a new hypothesis to minimize its occurrence in high-risk cases. Eur J Ophthalmol. 2004;14(4):325. doi:https://doi.org/10.1177/112067210401400408.
- Donmez O, Kilinc H, Ozbek Z, Saatci AO. Bilateral choroidal detachment maleate and brinzolamide. Med Hypothesis Discovery Innovation Ophthalmol. 2016;5:121.
- Katz L. Ciliochoroidal detachment. Ophthalmic Surg Lasers Imaging Retina. 1987;18:175.
- Tran HV, Ravinet E, Schnyder C, Reichhart M, Guex-Crosier Y. Blood-brain barrier disruption associated with topiramate-induced angle-closure glaucoma of acute onset. Klinische Monatsblätter für Augenheilkunde. 2006 May;223(5):425–427. doi:https://doi.org/10.1055/s-2006-926600.
- Russell-Jones R. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology. J Am Acad Dermatol. 2003;48(1):93–102. doi:https://doi.org/10.1067/mjd.2003.45.
- Aronow ME. Intraocular lymphoma. In: Retinal and Choroidal Imaging in Systemic Diseases. Singapore: Springer; 2018:231–248.
- Rodríguez-Blanco M, Piñeiro A, Bande M, López-Valladares M. Angle-closure glaucoma secondary to topiramate use. Archivos de la Sociedad Española de Oftalmología (English Edition). 2012;87(4):122–124. doi:https://doi.org/10.1016/j.oftale.2011.07.001.
- Végh M, Hári-Kovács A, Réz K, Tapasztó B, Szabó Á, Facskó A. Indapamide- induced transient myopia with supraciliary effusion: case report. BMC Ophthalmol. 2013;13(1):58. doi:https://doi.org/10.1186/1471-2415-13-58.
- Pe’er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009;17(5):299–306. doi:https://doi.org/10.3109/09273940903370755.
- Mulay K, Narula R, Honavar SG. Primary vitreoretinal lymphoma. Indian J Ophthalmol. 2015;63(3):180. doi:https://doi.org/10.4103/0301-4738.156903.